Form 4: Medpace Holdings Director Acquires Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Medpace Holdings director Cornelius P. McCarthy III acquired 198 restricted stock units, which vest in four equal installments throughout 2025.

Summary

  • Cornelius P. McCarthy III, a director at Medpace Holdings, Inc., reported a transaction involving the acquisition of restricted stock units.
  • The transaction occurred on November 29, 2024.
  • Mr. McCarthy acquired 198 restricted stock units.
  • These units represent a contingent right to receive one share of MEDP common stock each.
  • The restricted stock units will vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
  • Following the transaction, Mr. McCarthy directly owns 198 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it indicates alignment of interests between management and shareholders. There is no indication of any negative sentiment.

Positives

  • The acquisition of restricted stock units by a director signals confidence in the company's future performance.
  • The vesting schedule provides an incentive for the director to remain engaged with the company's success over the next year.

Industry Context

This is a standard transaction for a director of a public company, often used as part of their compensation package to align their interests with those of the shareholders.

Comparison to Industry Standards

  • Restricted stock unit grants are a common form of equity compensation for directors in publicly traded companies, particularly in the healthcare and pharmaceutical sectors.
  • The vesting schedule of four equal installments over a year is also a typical practice to incentivize long-term commitment.
  • Companies like IQVIA and ICON also use similar equity compensation methods for their directors.

Stakeholder Impact

  • The acquisition of restricted stock units by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

DateDescription
11/29/2024Date of the transaction where restricted stock units were acquired.
12/03/2024Date the Form 4 was signed.
03/31/2025First vesting date for the restricted stock units.
06/30/2025Second vesting date for the restricted stock units.
09/30/2025Third vesting date for the restricted stock units.
12/31/2025Final vesting date for the restricted stock units.

Keywords

Medpace Holdings, restricted stock units, insider trading, Form 4, director, equity compensation, MEDP

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.